Sanofi Consumer Healthcare reported unaudited Q1 FY26 revenue of ₹2,292 million, a 33% increase from the same quarter last year.
Net profit for the quarter stood at ₹678 million, with domestic sales growing 15.5% and export sales surging 144.4%.
The Board approved results reflecting the successful relaunch of key products previously recalled in 2024.
The company recognized a ₹24 million past service cost impact from new Indian labor codes effective November 2025.